2nd Quarter - Report
THE KPM GROUP DC LLC for RARE DISEASE COMPANY COALITION
Firm
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 373 H.R. 4472 H.R. 7667 S. 4348 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act Orphan Drug Tax Credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES | — |
| PATROSKI LAWSON | — |
| AMANDA MALAKOFF New | — |
| YOKO ROSENBAUM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.